The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XII.f

Cardiomyopathy (acute, subacute, chronic)

Publications

Thoi F, Scherer DJ, Kaye DM, Sanders P, Stokes MB

Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical Challenges.

Heart, lung & circulation. 2022;31(5):616-622

Schürer S, Klingel K, Sandri M, Majunke N, Besler C, Kandolf R, Lurz P, Luck M, Hertel P, Schuler G, Linke A, Mangner N

Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy.

JACC. Heart failure. 2017;5(6):435-445

Karch SB

The unique histology of methamphetamine cardiomyopathy: a case report.

Forensic science international. 2011;212(1-3):e1-4

Kaye S, Darke S, Duflou J, McKetin R

Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.

Addiction (Abingdon, England). 2008;103(8):1353-60

Yeo KK, Wijetunga M, Ito H, Efird JT, Tay K, Seto TB, Alimineti K, Kimata C, Schatz IJ

The association of methamphetamine use and cardiomyopathy in young patients.

The American journal of medicine. 2007;120(2):165-71

Hong R, Matsuyama E, Nur K

Cardiomyopathy associated with the smoking of crystal methamphetamine.

JAMA. 1991;265(9):1152-4